• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发含噻吩的三芳基吡唑啉衍生物作为 PI3Kγ 抑制剂。

Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors.

机构信息

School of Chemistry and Chemical Engineering, Nantong University, Nantong 226019, China.

State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210023, China.

出版信息

Molecules. 2022 Apr 8;27(8):2404. doi: 10.3390/molecules27082404.

DOI:10.3390/molecules27082404
PMID:35458602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027920/
Abstract

A series of new thiophene-containing triaryl pyrazoline derivatives, -, were synthesized and evaluated regarding PI3K inhibition activity and anti-tumor potency based on a trial of introducing significant moieties, including pyrazoline and thiophene, and simplifying the parallel ring structures. Most of the tested compounds indicated potent PI3K inhibitory potency, with this series of compounds showing more potency for PI3Kγ than PI3Kα. The top hit seemed more potent than the positive control on inhibiting PI3Kγ (IC values: 0.066 μM versus 0.777 μM) and more selective from PI3Kα (Index values: 645 versus 1.74). It could be inferred that the combination of - and -, as well as the modification of the electron-donating moieties, led to the improvement in potency. The anti-proliferation inhibitory activity and the enzymatic inhibition potency indicated consistent tendencies. The top hit could inhibit the phosphorylation of Akt by inhibiting PI3K through the PI3K-Akt-mTOR pathway. The molecular docking simulation indicated that the binding pattern of into PI3Kγ was preferable than that of PI3Kα, with more hydrogen bond, more π-involved interactions, and fewer π-sulfur interactions. The information in this work is referable for the further development of selective inhibitors for specific isoforms of PI3K.

摘要

一系列新的含噻吩的三芳基吡唑啉衍生物、-、被合成并评估了其对 PI3K 抑制活性和抗肿瘤活性,这是基于引入显著部分的尝试,包括吡唑啉和噻吩,并简化了平行环结构。大多数测试的化合物表现出很强的 PI3K 抑制活性,这一系列化合物对 PI3Kγ 的活性比 PI3Kα 更强。顶级命中物似乎比阳性对照物在抑制 PI3Kγ 方面更有效(IC 值:0.066 μM 对 0.777 μM),对 PI3Kα 的选择性更高(指数值:645 对 1.74)。可以推断,-和-的结合以及供电子部分的修饰导致了活性的提高。抗增殖抑制活性和酶抑制活性显示出一致的趋势。顶级命中物-通过抑制 PI3K 途径通过 PI3K-Akt-mTOR 途径抑制 Akt 的磷酸化。分子对接模拟表明,与 PI3Kα 相比,-与 PI3Kγ 的结合模式更可取,具有更多的氢键、更多的π 参与相互作用和更少的π-硫相互作用。这项工作中的信息可用于进一步开发针对特定 PI3K 同工型的选择性抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/8de702461c47/molecules-27-02404-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/6acd5729cd54/molecules-27-02404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/72b9f75681a5/molecules-27-02404-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/8c216a5e55e2/molecules-27-02404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/8de702461c47/molecules-27-02404-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/6acd5729cd54/molecules-27-02404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/72b9f75681a5/molecules-27-02404-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/8c216a5e55e2/molecules-27-02404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9170/9027920/8de702461c47/molecules-27-02404-g003a.jpg

相似文献

1
Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors.开发含噻吩的三芳基吡唑啉衍生物作为 PI3Kγ 抑制剂。
Molecules. 2022 Apr 8;27(8):2404. doi: 10.3390/molecules27082404.
2
Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity.新型 2,3,4,5-四取代噻吩衍生物的设计、合成及作为具有强大抗肿瘤活性的 PI3Kα 抑制剂的生物活性。
Eur J Med Chem. 2020 Jul 1;197:112309. doi: 10.1016/j.ejmech.2020.112309. Epub 2020 Apr 19.
3
Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold.具有吡唑啉骨架的 4-吗啉基-7,8-二氢-5H-噻吩并[4,3-d]嘧啶衍生物的合成及构效关系研究。
Molecules. 2017 Oct 31;22(11):1870. doi: 10.3390/molecules22111870.
4
Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition.吡唑啉衍生物作为微管蛋白聚合抑制剂,对血管内皮生长因子受体 2 具有抑制作用。
Bioorg Chem. 2021 Sep;114:105134. doi: 10.1016/j.bioorg.2021.105134. Epub 2021 Jul 1.
5
Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR.通过双重抑制PI3K/mTOR发现新型1,3,5-三嗪衍生物作为宫颈癌的有效抑制剂
Bioorg Med Chem. 2021 Feb 15;32:115997. doi: 10.1016/j.bmc.2021.115997. Epub 2021 Jan 6.
6
Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.发现2-(2-氨基嘧啶-5-基)-4-吗啉代-N-(吡啶-3-基)喹唑啉-7-胺作为新型PI3K/mTOR抑制剂和抗癌剂。
Eur J Med Chem. 2016 Jan 27;108:644-654. doi: 10.1016/j.ejmech.2015.11.038. Epub 2015 Dec 2.
7
Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition.含芳酰腙或芳酰肼部分的噻吩并[3,2-d]嘧啶衍生物的设计、合成及对 PI3K 和 mTOR 的双重抑制作用的生物评价。
Bioorg Chem. 2020 Nov;104:104197. doi: 10.1016/j.bioorg.2020.104197. Epub 2020 Aug 28.
8
Design, Synthesis and Molecular Docking Studies of Pyrazoline Derivatives as PI3K Inhibitors.设计、合成及吡唑啉衍生物作为 PI3K 抑制剂的分子对接研究。
Comb Chem High Throughput Screen. 2024;27(2):256-272. doi: 10.2174/1386207326666230504163312.
9
Structural optimization towards promising β-methyl-4-acrylamido quinoline derivatives as PI3K/mTOR dual inhibitors for anti-cancer therapy: The in vitro and in vivo biological evaluation.作为用于抗癌治疗的PI3K/mTOR双重抑制剂的有前景的β-甲基-4-丙烯酰胺基喹啉衍生物的结构优化:体外和体内生物学评价
Eur J Med Chem. 2021 Mar 15;214:113249. doi: 10.1016/j.ejmech.2021.113249. Epub 2021 Feb 1.
10
Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS/PI3K/Akt/JNK inhibition in breast carcinoma cells.嘧啶-2-硫酮衍生物的合成、分子对接及体外研究:通过潜在的 RAS/PI3K/Akt/JNK 抑制作用在乳腺癌细胞中作为抗肿瘤剂。
Sci Rep. 2022 Dec 22;12(1):22146. doi: 10.1038/s41598-022-26571-7.

本文引用的文献

1
Novel Dual PI3K/mTOR Inhibitor, Apitolisib (GDC-0980), Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells.新型双重 PI3K/mTOR 抑制剂,阿皮替尼(GDC-0980),抑制人胶质母细胞瘤细胞的生长并诱导其凋亡。
Int J Mol Sci. 2021 Oct 26;22(21):11511. doi: 10.3390/ijms222111511.
2
Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review).PI3K 抑制剂的研发:临床试验进展及新策略(综述)。
Pharmacol Res. 2021 Nov;173:105900. doi: 10.1016/j.phrs.2021.105900. Epub 2021 Sep 20.
3
Structure of the phosphoinositide 3-kinase (PI3K) p110γ-p101 complex reveals molecular mechanism of GPCR activation.
磷酸肌醇3激酶(PI3K)p110γ-p101复合物的结构揭示了G蛋白偶联受体激活的分子机制。
Sci Adv. 2021 Aug 27;7(35). doi: 10.1126/sciadv.abj4282. Print 2021 Aug.
4
The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review.PI3K/AKT信号通路在癌症发生和耐药中的致病作用:最新综述
Cancers (Basel). 2021 Aug 5;13(16):3949. doi: 10.3390/cancers13163949.
5
Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents.丝裂原活化蛋白激酶抑制剂作为潜在抗癌药物的最新研究进展。
Bioorg Chem. 2021 Sep;114:105161. doi: 10.1016/j.bioorg.2021.105161. Epub 2021 Jul 13.
6
Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation.Pax5 通过下调 PTEN 促进 PI3K 信号传导来调节 B 细胞免疫。
Sci Immunol. 2021 Jul 23;6(61). doi: 10.1126/sciimmunol.abg5003.
7
Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition.吡唑啉衍生物作为微管蛋白聚合抑制剂,对血管内皮生长因子受体 2 具有抑制作用。
Bioorg Chem. 2021 Sep;114:105134. doi: 10.1016/j.bioorg.2021.105134. Epub 2021 Jul 1.
8
PI3K inhibitors are finally coming of age.PI3K 抑制剂终于迎来了黄金时代。
Nat Rev Drug Discov. 2021 Oct;20(10):741-769. doi: 10.1038/s41573-021-00209-1. Epub 2021 Jun 14.
9
hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.通过叶酸功能化的聚乳酸-羟基乙酸共聚物纳米颗粒共负载磁性纳米颗粒/小干扰RNA/渥曼青霉素对卵巢癌细胞进行人端粒酶逆转录酶分子靶向治疗
Life Sci. 2021 Jul 15;277:119621. doi: 10.1016/j.lfs.2021.119621. Epub 2021 May 15.
10
Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016-2020).磷脂酰肌醇 3-激酶(PI3K)抑制剂:抑制剂设计和临床试验的最新进展(2016-2020 年)。
Expert Opin Ther Pat. 2021 Oct;31(10):877-892. doi: 10.1080/13543776.2021.1924150. Epub 2021 May 16.